345 related articles for article (PubMed ID: 22642224)
1. Amyloid substance within stenotic aortic valves promotes mineralization.
Audet A; Côté N; Couture C; Bossé Y; Després JP; Pibarot P; Mathieu P
Histopathology; 2012 Oct; 61(4):610-9. PubMed ID: 22642224
[TBL] [Abstract][Full Text] [Related]
2. Autotaxin Derived From Lipoprotein(a) and Valve Interstitial Cells Promotes Inflammation and Mineralization of the Aortic Valve.
Bouchareb R; Mahmut A; Nsaibia MJ; Boulanger MC; Dahou A; Lépine JL; Laflamme MH; Hadji F; Couture C; Trahan S; Pagé S; Bossé Y; Pibarot P; Scipione CA; Romagnuolo R; Koschinsky ML; Arsenault BJ; Marette A; Mathieu P
Circulation; 2015 Aug; 132(8):677-90. PubMed ID: 26224810
[TBL] [Abstract][Full Text] [Related]
3. Elevated expression of lipoprotein-associated phospholipase A2 in calcific aortic valve disease: implications for valve mineralization.
Mahmut A; Boulanger MC; El Husseini D; Fournier D; Bouchareb R; Després JP; Pibarot P; Bossé Y; Mathieu P
J Am Coll Cardiol; 2014 Feb; 63(5):460-9. PubMed ID: 24161325
[TBL] [Abstract][Full Text] [Related]
4. High-density lipoproteins (HDL) are present in stenotic aortic valves and may interfere with the mechanisms of valvular calcification.
Lommi JI; Kovanen PT; Jauhiainen M; Lee-Rueckert M; Kupari M; Helske S
Atherosclerosis; 2011 Dec; 219(2):538-44. PubMed ID: 21917259
[TBL] [Abstract][Full Text] [Related]
5. ApoC-III is a novel inducer of calcification in human aortic valves.
Schlotter F; de Freitas RCC; Rogers MA; Blaser MC; Wu PJ; Higashi H; Halu A; Iqbal F; Andraski AB; Rodia CN; Kuraoka S; Wen JR; Creager M; Pham T; Hutcheson JD; Body SC; Kohan AB; Sacks FM; Aikawa M; Singh SA; Aikawa E
J Biol Chem; 2021; 296():100193. PubMed ID: 33334888
[TBL] [Abstract][Full Text] [Related]
6. Simulation of early calcific aortic valve disease in a 3D platform: A role for myofibroblast differentiation.
Hjortnaes J; Goettsch C; Hutcheson JD; Camci-Unal G; Lax L; Scherer K; Body S; Schoen FJ; Kluin J; Khademhosseini A; Aikawa E
J Mol Cell Cardiol; 2016 May; 94():13-20. PubMed ID: 26996755
[TBL] [Abstract][Full Text] [Related]
7. Increased thrombospondin-2 in human fibrosclerotic and stenotic aortic valves.
Pohjolainen V; Mustonen E; Taskinen P; Näpänkangas J; Leskinen H; Ohukainen P; Peltonen T; Aro J; Juvonen T; Satta J; Ruskoaho H; Rysä J
Atherosclerosis; 2012 Jan; 220(1):66-71. PubMed ID: 22035575
[TBL] [Abstract][Full Text] [Related]
8. Histopathological assessment of calcification and inflammation of calcific aortic valves from patients with and without diabetes mellitus.
Mosch J; Gleissner CA; Body S; Aikawa E
Histol Histopathol; 2017 Mar; 32(3):293-306. PubMed ID: 27353274
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor-β1 promotes fibrosis but attenuates calcification of valvular tissue applied as a three-dimensional calcific aortic valve disease model.
Jenke A; Kistner J; Saradar S; Chekhoeva A; Yazdanyar M; Bergmann AK; Rötepohl MV; Lichtenberg A; Akhyari P
Am J Physiol Heart Circ Physiol; 2020 Nov; 319(5):H1123-H1141. PubMed ID: 32986963
[TBL] [Abstract][Full Text] [Related]
10. Heat shock protein 90 is downregulated in calcific aortic valve disease.
Weisell J; Ohukainen P; Näpänkangas J; Ohlmeier S; Bergmann U; Peltonen T; Taskinen P; Ruskoaho H; Rysä J
BMC Cardiovasc Disord; 2019 Dec; 19(1):306. PubMed ID: 31856737
[TBL] [Abstract][Full Text] [Related]
11. ATP acts as a survival signal and prevents the mineralization of aortic valve.
Côté N; El Husseini D; Pépin A; Guauque-Olarte S; Ducharme V; Bouchard-Cannon P; Audet A; Fournier D; Gaudreault N; Derbali H; McKee MD; Simard C; Després JP; Pibarot P; Bossé Y; Mathieu P
J Mol Cell Cardiol; 2012 May; 52(5):1191-202. PubMed ID: 22366713
[TBL] [Abstract][Full Text] [Related]
12. COX-2 Is Downregulated in Human Stenotic Aortic Valves and Its Inhibition Promotes Dystrophic Calcification.
Vieceli Dalla Sega F; Fortini F; Cimaglia P; Marracino L; Tonet E; Antonucci A; Moscarelli M; Campo G; Rizzo P; Ferrari R
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255450
[TBL] [Abstract][Full Text] [Related]
13. Expression of bone sialoprotein and bone morphogenetic protein-2 in calcific aortic stenosis.
Kaden JJ; Bickelhaupt S; Grobholz R; Vahl CF; Hagl S; Brueckmann M; Haase KK; Dempfle CE; Borggrefe M
J Heart Valve Dis; 2004 Jul; 13(4):560-6. PubMed ID: 15311861
[TBL] [Abstract][Full Text] [Related]
14. Nucleotide ecto-enzyme metabolic pattern and spatial distribution in calcific aortic valve disease; its relation to pathological changes and clinical presentation.
Kutryb-Zajac B; Jablonska P; Serocki M; Bulinska A; Mierzejewska P; Friebe D; Alter C; Jasztal A; Lango R; Rogowski J; Bartoszewski R; Slominska EM; Chlopicki S; Schrader J; Yacoub MH; Smolenski RT
Clin Res Cardiol; 2020 Feb; 109(2):137-160. PubMed ID: 31144065
[TBL] [Abstract][Full Text] [Related]
15. Increased Calcific Aortic Valve Disease in response to a diabetogenic, procalcific diet in the LDLr
Scatena M; Jackson MF; Speer MY; Leaf EM; Wallingford MC; Giachelli CM
Cardiovasc Pathol; 2018; 34():28-37. PubMed ID: 29539583
[TBL] [Abstract][Full Text] [Related]
16. Lipoprotein lipase in aortic valve stenosis is associated with lipid retention and remodelling.
Mahmut A; Boulanger MC; Fournier D; Couture C; Trahan S; Pagé S; Arsenault B; Després JP; Pibarot P; Mathieu P
Eur J Clin Invest; 2013 Jun; 43(6):570-8. PubMed ID: 23550604
[TBL] [Abstract][Full Text] [Related]
17. Bone regulatory factors NFATc1 and Osterix in human calcific aortic valves.
Alexopoulos A; Bravou V; Peroukides S; Kaklamanis L; Varakis J; Alexopoulos D; Papadaki H
Int J Cardiol; 2010 Mar; 139(2):142-9. PubMed ID: 19019468
[TBL] [Abstract][Full Text] [Related]
18. Integrative Multi-Omics Analysis in Calcific Aortic Valve Disease Reveals a Link to the Formation of Amyloid-Like Deposits.
Heuschkel MA; Skenteris NT; Hutcheson JD; van der Valk DD; Bremer J; Goody P; Hjortnaes J; Jansen F; Bouten CVC; van den Bogaerdt A; Matic L; Marx N; Goettsch C
Cells; 2020 Sep; 9(10):. PubMed ID: 32987857
[TBL] [Abstract][Full Text] [Related]
19. Inflammation is associated with the remodeling of calcific aortic valve disease.
Coté N; Mahmut A; Bosse Y; Couture C; Pagé S; Trahan S; Boulanger MC; Fournier D; Pibarot P; Mathieu P
Inflammation; 2013 Jun; 36(3):573-81. PubMed ID: 23225202
[TBL] [Abstract][Full Text] [Related]
20. The progression of calcific aortic valve disease through injury, cell dysfunction, and disruptive biologic and physical force feedback loops.
Li C; Xu S; Gotlieb AI
Cardiovasc Pathol; 2013; 22(1):1-8. PubMed ID: 22795219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
